Aprepitant: Difference between revisions

← Older edit

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

Alexander Berchansky, Michal Harel

Revision as of 16:30, 27 December 2023 view source Alexander Berchansky (talk \| contribs) 29,637 edits No edit summary ← Older edit		Latest revision as of 14:33, 21 January 2024 view source Michal Harel (talk \| contribs) 31,761 edits No edit summary
Line 1:		Line 1:
	<StructureSection load='' size='340' side='right' caption='~~Caption for this structure~~' scene='10/1020314/Cv/1'>		<StructureSection load='' size='340' side='right' caption='Aprepitant' scene='10/1020314/Cv/1'>
	Aprepitant, sold under the brand name Emend among others, is a medication used to prevent chemotherapy-induced nausea and vomiting (CINV) and to prevent postoperative nausea and vomiting (PONV). It may be used together with ondansetron and dexamethasone.<ref name="a4">[https://www.drugs.com/monograph/aprepitant-fosaprepitant.html "Aprepitant/Fosaprepitant Dimeglumine Monograph for Professionals".] Drugs.com. Archived from the original on 13 August 2020. Retrieved 13 October 2019.</ref> See also [https://en.wikipedia.org/wiki/Aprepitant Aprepitant].		Aprepitant, sold under the brand name Emend among others, is a medication used to prevent chemotherapy-induced nausea and vomiting (CINV) and to prevent postoperative nausea and vomiting (PONV). It may be used together with ondansetron and dexamethasone.<ref name="a4">[https://www.drugs.com/monograph/aprepitant-fosaprepitant.html "Aprepitant/Fosaprepitant Dimeglumine Monograph for Professionals".] Drugs.com. Archived from the original on 13 August 2020. Retrieved 13 October 2019.</ref> See also [https://en.wikipedia.org/wiki/Aprepitant Aprepitant].